Microbix Biosystems Inc. is a Canada-based company. The Company develops and commercializes proprietary biological and technology solutions for human health and wellbeing. It manufactures a range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment and proficiency testing controls (QAPsTM business), and sample collection devices (DxTMTM business). The Company operates in two ways: (i) the development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples, and (ii) the development and commercialization of novel and proprietary products or technologies such as Kinlytic. It's Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots.
Company Information
About this company
Key people
Cameron L. Groome
President, Chief Executive Officer and Director
Martin A. Marino
Independent Chairman of the Board
Peter M. Blecher
Independent Director
Mark A. Cochran
Independent Director
Vaughn C. Embro-pantalony
Independent Director
Joseph D. Renner
Independent Director
Click to see more
Key facts
- Shares in issue138.81m
- EPICMBX
- ISINCA59501P1045
- LocationCanada
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market capCA$29.84m
- Employees69
- ExchangeToronto Stock Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.